8-K
filed March 3, 2026, 6:59 PM ET
ticker UAN
CIK 0001425292
regulatory
confidence high
sentiment negative
materiality 0.50
CVR Partners loses independent director; audit committee falls below NYSE minimum of 3 members
CVR PARTNERS, LP
- Director Brian A. Goebel passed away on February 20, 2026; he was chair of the Audit Committee.
- Board reduced to 5 members, only 2 independent; Audit Committee now has 2 members, both independent.
- Partnership notifies NYSE of non-compliance with Section 303A.07(a) requiring at least 3 audit committee members.
- Partnership initiated search for a new independent director and expects to regain compliance upon appointment.
- NYSE issued notice of non-compliance on March 3, 2026; no trading suspension immediately threatened.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001425292-26-000014
- form_type
- 8-K
- ticker
- UAN
- cik
- 0001425292
- company_name
- CVR PARTNERS, LP
- filed_at
- 2026-03-03T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:35.054539+00:00
- generated_at
- 2026-05-15T22:08:00.858837+00:00
- sec_items
- ["3.01"]
- event_type
- regulatory
- sentiment
- negative
- materiality_score
- 0.5
- calibrated_materiality_score
- 0.5
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001425292-26-000014
- json_url
- https://secwatch.observer/filing/0001425292-26-000014.json
- markdown_url
- https://secwatch.observer/filing/0001425292-26-000014.md
- text_url
- https://secwatch.observer/filing/0001425292-26-000014.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1425292/000142529226000014/0001425292-26-000014-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1425292/000142529226000014/cvi-20260225.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
CETY
Clean Energy Technologies receives Nasdaq delisting notice for late Q1 filing
Clean Energy Technologies, Inc.
May 29, 2026, 4:57 PM ET
regulatory
Items 3.01
same fact type: exchange_compliance_notice
same SEC item: 3.01
same event type: regulatory
similar materiality
This filing
March 3, 2026, the Partnership received notice from the NYSE that it became non-compliant with the audit committee requirement set forth in Listed Company Manual Section 303A.07(a) as a result of Mr. Goebel’s death. The Partnership has initiated a search for a new independent director to join the Board and the Audit Committee and expects to announce a replacement as soon as reasonably practicable. Upon appointing a new member of the Audit Committee that meets the independence requirements of Section 10A of, and Rule 10A-3 under, the Securities Exchange Act of 1934, as amended, and Section 303A
Comparable filing
May 26, 2026, Clean Energy Technologies, Inc. (the “ Company ”) received a written notice (the “ Notice ”)
from the Listing Qualifications Department of The Nasdaq Stock Market (“ Nasdaq ”) indicating that the Company is not
in compliance with Nasdaq Listing Rule 5250(c)(1) (the “ Rule ”) because the Company had not yet filed its Quarterly
Report on Form 10-Q for the period ended March 31, 2026 (the “ Quarterly Report ”). The
Rule requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission. The Notice has
no immediate effect on the listing
Filing page
SEC filing
FTHM
Fathom Holdings receives Nasdaq notice for late Q1 2026 10-Q filing; 60 days to submit plan
Fathom Holdings Inc.
May 29, 2026, 4:15 PM ET
regulatory
Items 3.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01
same event type: regulatory
similar materiality
This filing
March 3, 2026, the Partnership received notice from the NYSE that it became non-compliant with the audit committee requirement set forth in Listed Company Manual Section 303A.07(a) as a result of Mr. Goebel’s death. The Partnership has initiated a search for a new independent director to join the Board and the Audit Committee and expects to announce a replacement as soon as reasonably practicable. Upon appointing a new member of the Audit Committee that meets the independence requirements of Section 10A of, and Rule 10A-3 under, the Securities Exchange Act of 1934, as amended, and Section 303A
Comparable filing
May 22, 2026, Fathom Holdings Inc. (the “Company”) received a notification letter from the Nasdaq Stock Market LLC (“Nasdaq”) indicating that, because the Company has not yet filed its Quarterly Report on Form 10-Q for the period ended March 31, 2026 (the “Form 10-Q”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of all required periodic financial reports with the Securities and Exchange Commission (the “Filing Requirement”). In accordance with Nasdaq’s listing rules, the Company has 60 calendar days from the date of the notification letter
Filing page
SEC filing
LASE
Laser Photonics receives Nasdaq delisting notice for late Q1 2026 10-Q
Laser Photonics Corp
May 22, 2026, 5:27 PM ET
regulatory
Items 3.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01
same event type: regulatory
similar materiality
This filing
March 3, 2026, the Partnership received notice from the NYSE that it became non-compliant with the audit committee requirement set forth in Listed Company Manual Section 303A.07(a) as a result of Mr. Goebel’s death. The Partnership has initiated a search for a new independent director to join the Board and the Audit Committee and expects to announce a replacement as soon as reasonably practicable. Upon appointing a new member of the Audit Committee that meets the independence requirements of Section 10A of, and Rule 10A-3 under, the Securities Exchange Act of 1934, as amended, and Section 303A
Comparable filing
received a notice from Nasdaq Listing Qualifications
department of the Nasdaq Stock Market LLC (“Nasdaq”) stating that since it had not received the Company’s Form 10-Q
for the period ended March 31, 2026, the Company does not comply with Nasdaq’s Listing Rules for continued listing. Nasdaq stated
that the Company has 60 days to submit a plan to regain compliance with respect to this delinquent report. Nasdaq can grant an exception
to allow the Company to regain compliance up to a maximum of 180 calendar days from the due date of the Initial Delinquent Filing, or
November 16, 2026. A
copy of t
Filing page
SEC filing
RICK
RCI receives Nasdaq noncompliance notice for late Q2 10-Q; deadline July 20
RCI HOSPITALITY HOLDINGS, INC.
May 22, 2026, 4:23 PM ET
regulatory
Items 3.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01
same event type: regulatory
similar materiality
This filing
March 3, 2026, the Partnership received notice from the NYSE that it became non-compliant with the audit committee requirement set forth in Listed Company Manual Section 303A.07(a) as a result of Mr. Goebel’s death. The Partnership has initiated a search for a new independent director to join the Board and the Audit Committee and expects to announce a replacement as soon as reasonably practicable. Upon appointing a new member of the Audit Committee that meets the independence requirements of Section 10A of, and Rule 10A-3 under, the Securities Exchange Act of 1934, as amended, and Section 303A
Comparable filing
May 20, 2026, RCI Hospitality Holdings, Inc. (“we,” “us” and the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that we are
Filing page
SEC filing
AVXL
Anavex receives Nasdaq delinquency notice for late 10-Q filing; deadline July 20, 2026
ANAVEX LIFE SCIENCES CORP.
May 22, 2026, 8:15 AM ET
regulatory
Items 3.01, 8.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01
same event type: regulatory
similar materiality
This filing
March 3, 2026, the Partnership received notice from the NYSE that it became non-compliant with the audit committee requirement set forth in Listed Company Manual Section 303A.07(a) as a result of Mr. Goebel’s death. The Partnership has initiated a search for a new independent director to join the Board and the Audit Committee and expects to announce a replacement as soon as reasonably practicable. Upon appointing a new member of the Audit Committee that meets the independence requirements of Section 10A of, and Rule 10A-3 under, the Securities Exchange Act of 1934, as amended, and Section 303A
Comparable filing
May 20, 2026, Anavex Life Sciences Corp. (the “Company”)
received a delinquency notification letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market
LLC (“Nasdaq”) indicating that, as
Filing page
SEC filing
GTBP
GT Biopharma receives Nasdaq extension to Nov 16, 2026 to meet $1 minimum bid price
GT Biopharma, Inc.
May 22, 2026, 8:00 AM ET
regulatory
Items 3.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01
same event type: regulatory
similar materiality
This filing
March 3, 2026, the Partnership received notice from the NYSE that it became non-compliant with the audit committee requirement set forth in Listed Company Manual Section 303A.07(a) as a result of Mr. Goebel’s death. The Partnership has initiated a search for a new independent director to join the Board and the Audit Committee and expects to announce a replacement as soon as reasonably practicable. Upon appointing a new member of the Audit Committee that meets the independence requirements of Section 10A of, and Rule 10A-3 under, the Securities Exchange Act of 1934, as amended, and Section 303A
Comparable filing
May 20, 2026, GT Biopharma, Inc., a Delaware corporation (the “Company”), received a letter from the Nasdaq Listing Qualifications
Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that
Filing page
SEC filing
MYPS
PLAYSTUDIOS receives Nasdaq Capital Market transfer; second compliance period to Nov 2, 2026
PLAYSTUDIOS, Inc.
May 5, 2026, 7:59 PM ET
regulatory
Items 3.01
same fact type: exchange_compliance_notice
same SEC item: 3.01
same event type: regulatory
similar materiality
This filing
March 3, 2026, the Partnership received notice from the NYSE that it became non-compliant with the audit committee requirement set forth in Listed Company Manual Section 303A.07(a) as a result of Mr. Goebel’s death. The Partnership has initiated a search for a new independent director to join the Board and the Audit Committee and expects to announce a replacement as soon as reasonably practicable. Upon appointing a new member of the Audit Committee that meets the independence requirements of Section 10A of, and Rule 10A-3 under, the Securities Exchange Act of 1934, as amended, and Section 303A
Comparable filing
May 5, 2026, Nasdaq staff approved the Company’s application to transfer its listing to the Nasdaq Capital Market. The transfer will become effective at the opening of business on May 6, 2026 (the “Transfer Date”) and wi
Filing page
SEC filing
HOTH
Hoth Therapeutics receives Nasdaq deficiency notice for minimum bid price non-compliance
Hoth Therapeutics, Inc.
May 4, 2026, 7:59 PM ET
regulatory
Items 3.01
same fact type: exchange_compliance_notice
same SEC item: 3.01
same event type: regulatory
similar materiality
This filing
March 3, 2026, the Partnership received notice from the NYSE that it became non-compliant with the audit committee requirement set forth in Listed Company Manual Section 303A.07(a) as a result of Mr. Goebel’s death. The Partnership has initiated a search for a new independent director to join the Board and the Audit Committee and expects to announce a replacement as soon as reasonably practicable. Upon appointing a new member of the Audit Committee that meets the independence requirements of Section 10A of, and Rule 10A-3 under, the Securities Exchange Act of 1934, as amended, and Section 303A
Comparable filing
April 30, 2026, Hoth
Therapeutics, Inc. (the “Company”) was notified (the “Notification Letter”) by The Nasdaq Stock Market, LLC (“Nasdaq”) that
it is not in compliance with the minimum bid price requirements set forth i
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.